EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response

David D B Bates, Maria El Homsi, Kevin J Chang, Neeraj Lalwani, Natally Horvat, Shannon P Sheedy

Clinical Colorectal Cancer · 2022-03 · 21 (1) · 10-18

DOI: 10.1016/j.clcc.2021.10.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Colorectal Cancer, 2022-03. Verfasst von David D B Bates und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: batesd@mskcc.org. Hauptthemen laut MEDLINE: Rectal Neoplasms. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rectal cancer is a relatively common malignancy in the United States. Magnetic resonance imaging (MRI) of rectal cancer has evolved tremendously in recent years, and has become a key component of baseline staging and treatment planning. In addition to assessing the primary tumor and locoregional lymph nodes, rectal MRI can be used to help with risk stratification by identifying high-risk features such as extramural vascular invasion and can assess treatment response for patients receiving neoadjuvant therapy. As the practice of rectal MRI continues to expand further into academic centers and private practices, standard MRI protocols, and reporting are critical. In addition, it is imperative that the radiologists reading these cases work closely with surgeons, medical oncologists, radiation oncologists, and pathologists to ensure we are providing the best possible care to patients. This review aims to provide a broad overview of the role of MRI for rectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsHumansLymph NodesMagnetic Resonance ImagingNeoplasm InvasivenessNeoplasm StagingRetrospective Studies

Stichwörter der Autor:innen

Cancer stagingMRIRadiologyRectal cancer

Autor:innen und Institutionen

  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: batesd@mskcc.org.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Department of Radiology, Boston University Medical Center, Boston, MA.
  • Department of Radiology, Virginia Commonwealth University, Richmond, VA.
  • Department of Radiology, Mayo Clinic, Rochester, MN.

Förderung

  • NCI NIH HHS
  • NIH

Zitieren

APA

Bates, D. D. B., Homsi, M. E., Chang, K. J., Lalwani, N., Horvat, N., & Sheedy, S. P. (2022). MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response. Clinical Colorectal Cancer, 21(1), 10-18. https://doi.org/10.1016/j.clcc.2021.10.007

Vancouver

Bates DDB, Homsi ME, Chang KJ, Lalwani N, Horvat N, Sheedy SP. MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response. Clinical Colorectal Cancer. 2022;21(1):10-18. doi:10.1016/j.clcc.2021.10.007

BibTeX
@article{Bates2022,
  author = {Bates, David D B and Homsi, Maria El and Chang, Kevin J and Lalwani, Neeraj and Horvat, Natally and Sheedy, Shannon P},
  title = {MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response},
  journal = {Clinical Colorectal Cancer},
  year = {2022},
  volume = {21},
  number = {1},
  pages = {10--18},
  doi = {10.1016/j.clcc.2021.10.007}
}
Kostenlos starten →